rx 821002 has been researched along with guanylyl imidodiphosphate in 5 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (guanylyl imidodiphosphate) | Trials (guanylyl imidodiphosphate) | Recent Studies (post-2010) (guanylyl imidodiphosphate) |
---|---|---|---|---|---|
317 | 0 | 45 | 2,356 | 1 | 18 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Etgen, AM; Karkanias, GB | 1 |
García-Sevilla, JA; Sastre, M | 1 |
Bétuing, S; Daviaud, D; Hickson, G; Lafontan, M; Lapalu, S; Peyroulan, D; Saulnier-Blache, JS; Valet, P | 1 |
Callado, LF; Meana, JJ | 1 |
Pihlavisto, M; Scheinin, M; Sjöholm, B; Wurster, S | 1 |
5 other study(ies) available for rx 821002 and guanylyl imidodiphosphate
Article | Year |
---|---|
A thermodynamic analysis of estrogen regulation of alpha 2-adrenoceptor binding.
Topics: Adrenergic alpha-Antagonists; Animals; Binding Sites; Binding, Competitive; Dioxanes; Estradiol; Female; Guanylyl Imidodiphosphate; Hypothalamus; Idazoxan; Ligands; Ovariectomy; Oxymetazoline; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Temperature; Thermodynamics | 1995 |
Alpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtype.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Binding, Competitive; Brain; Dioxanes; Edetic Acid; Female; Guanabenz; Guanylyl Imidodiphosphate; Humans; Idazoxan; Imidazoles; Indoles; Isoindoles; Isoquinolines; Male; Piperazines; Receptors, Adrenergic, alpha; Sodium Chloride; Tritium | 1994 |
Functional consequences of constitutively active alpha2A-adrenergic receptor expression in 3T3F442A preadipocytes and adipocytes.
Topics: 3T3 Cells; Adipocytes; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; Cell Division; Culture Media, Serum-Free; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Humans; Idazoxan; Kinetics; Lipolysis; Mice; Mutagenesis, Site-Directed; Phosphotyrosine; Quinoxalines; Receptors, Adrenergic, alpha-2; Recombinant Fusion Proteins; Sodium Chloride; Transfection | 1997 |
Low-affinity conditions for agonists increase the binding of the antagonist [3H]RX821002 to the alpha(2B/C)-adrenoceptor subtypes in human brain and rat kidney.
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Brain Chemistry; Guanylyl Imidodiphosphate; Humans; Idazoxan; Kidney; Male; Membranes; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tritium | 1997 |
Modulation of agonist binding to recombinant human alpha2-adrenoceptors by sodium ions.
Topics: Adrenergic alpha-Agonists; Allosteric Regulation; Animals; Binding, Competitive; Cations, Monovalent; Guanylyl Imidodiphosphate; Humans; Idazoxan; Mammary Neoplasms, Animal; Mice; Norepinephrine; Receptors, Adrenergic, alpha-2; Recombinant Proteins; Sodium; Tumor Cells, Cultured | 1998 |